Galal Cancer
Career Averages
PAPER Ratings | PAPER Components | Adjusted Rates | Adjusted Shooting Percentages | Adjusted Per-Game Stats | Raw Shooting Percentages | Raw Rates | Raw Per-Game Stats
PAPER Ratings (All Games)
| |
|
PRODUCTION |
|
Offensive Value-Add |
Defensive Value-Add |
Adjusted Shooting Percentages |
Adjusted Rate Stats |
Adjusted Per-Game Averages |
Raw Shooting Percentages |
Raw Rate Stats |
Raw Per-Game Averages |
| Season |
Player |
Team |
Class |
Position |
%Min. |
(RANK) |
Offense |
(Rank) |
Defense |
(Rank) |
VALUE |
(Rank) |
CLOUT |
(Rank) |
IMPACT |
(Rank) |
PRESTIGE |
(Rank) |
Shooting |
Free Throw |
Rebounding |
Ball Control |
Passing |
Shooting |
Shot-Blocking |
Rebounding |
Turnover |
Foul Control |
Adj. %FGA |
(RANK) |
Adj. eFG% |
(RANK) |
Adj. TS% |
(RANK) |
Adj. 2G% |
(RANK) |
Adj. 3G% |
(RANK) |
Adj. 3GA:FGA |
(RANK) |
Adj. FT% |
(RANK) |
Off. TO% |
(RANK) |
Setup% |
(RANK) |
Off. Reb% |
(RANK) |
Def. Reb% |
(RANK) |
Def. TO% |
(RANK) |
Steal% |
(RANK) |
Block% |
(RANK) |
MIN |
FGM |
FGA |
3GM |
3GA |
FTM |
FTA |
OREB |
DREB |
REB |
AST |
TO |
BLK |
STL |
PF |
Fdr |
PTS |
%FGA |
(RANK) |
eFG% |
(RANK) |
TS% |
(RANK) |
2G% |
(RANK) |
3G% |
(RANK) |
3GA:FGA |
(RANK) |
FT% |
(RANK) |
Off. TO% |
(RANK) |
Setup% |
(RANK) |
Off. Reb% |
(RANK) |
Def. Reb% |
(RANK) |
Def. TO% |
(RANK) |
Steal% |
(RANK) |
Block% |
(RANK) |
MIN |
FGM |
FGA |
3GM |
3GA |
FTM |
FTA |
OREB |
DREB |
REB |
AST |
TO |
BLK |
STL |
PF |
Fdr |
PTS |
| 2012 |
Galal Cancer |
CORN |
FR |
Combo |
51.6% |
(1658) |
12.25 |
(2992) |
18.62 |
(510) |
-6.37 |
(2751) |
34 |
(0) |
17 |
(0) |
507 |
() |
-5.42 |
(3342) |
-1.31 |
(2040) |
0.44 |
(880) |
-4.83 |
(3397) |
1.87 |
(255) |
-0.47 |
(1289) |
-0.38 |
(541) |
-0.20 |
(1213) |
-1.12 |
(331) |
0.92 |
(3172) |
20.5 |
(661) |
31.4 |
(2562) |
36.2 |
(2551) |
31.9 |
(2023) |
19.1 |
() |
14.5 |
(1886) |
55.3 |
(96) |
6.62 |
(3032) |
16.31 |
(193) |
4.13 |
(1765) |
9.97 |
(2012) |
4.04 |
(302) |
2.36 |
(288) |
0.84 |
(1536) |
20.7 |
1.7 |
5.5 |
0.2 |
0.8 |
1.4 |
2.5 |
0.8 |
1.9 |
2.6 |
0.0 |
2.6 |
0.2 |
0.9 |
2.6 |
2.2 |
4.8 |
20.5 |
(661) |
38.9 |
(2417) |
35.4 |
(2422) |
39.4 |
(1908) |
23.8 |
() |
13.3 |
(1882) |
55.3 |
(96) |
7.23 |
(3004) |
16.31 |
(193) |
3.79 |
(2401) |
10.20 |
(2317) |
5.21 |
(328) |
3.04 |
(303) |
1.09 |
(2178) |
21.0 |
2.2 |
5.9 |
0.2 |
0.8 |
1.6 |
2.8 |
0.7 |
1.8 |
2.5 |
2.6 |
2.6 |
0.2 |
1.1 |
3.2 |
2.5 |
6.1 |
| 2013 |
Galal Cancer |
CORN |
SO |
SG |
49.9% |
(1721) |
17.87 |
(1789) |
21.97 |
(1687) |
-4.10 |
(1848) |
59 |
(0) |
29 |
(0) |
507 |
() |
-3.07 |
(3031) |
-0.32 |
(1069) |
-0.01 |
(914) |
-0.75 |
(2781) |
2.31 |
(368) |
2.30 |
(3215) |
0.02 |
(1128) |
-0.79 |
(1307) |
0.19 |
(747) |
0.05 |
(2281) |
18.1 |
(1811) |
36.4 |
(2308) |
33.6 |
(2312) |
34.1 |
(1841) |
31.3 |
() |
17.7 |
(1687) |
72.9 |
() |
4.41 |
(2252) |
15.36 |
(1555) |
4.55 |
(1516) |
10.62 |
(1785) |
3.76 |
(627) |
1.98 |
(693) |
0.46 |
(1881) |
20.0 |
1.7 |
5.0 |
0.3 |
0.9 |
0.3 |
1.8 |
0.8 |
1.9 |
2.7 |
0.6 |
1.7 |
0.1 |
0.8 |
2.1 |
1.6 |
3.9 |
18.1 |
(1811) |
35.4 |
(2520) |
33.7 |
(2446) |
33.9 |
(2121) |
29.2 |
() |
15.9 |
(1840) |
72.9 |
() |
4.74 |
(2324) |
15.36 |
(1555) |
3.98 |
(1729) |
10.64 |
(1871) |
4.73 |
(627) |
2.52 |
(718) |
0.60 |
(1971) |
22.1 |
1.9 |
5.6 |
0.3 |
0.9 |
1.6 |
2.2 |
0.8 |
1.8 |
2.6 |
2.6 |
1.7 |
0.1 |
0.9 |
2.3 |
2.0 |
5.6 |
| 2015 |
Galal Cancer |
CORN |
SR |
Combo |
75.7% |
(521) |
20.65 |
(998) |
21.75 |
(1307) |
-1.10 |
(1048) |
84 |
(0) |
63 |
(0) |
519 |
() |
-1.81 |
(1170) |
0.76 |
(355) |
0.78 |
(576) |
-1.16 |
(2581) |
1.30 |
(411) |
0.35 |
(1104) |
-0.19 |
(952) |
0.40 |
(2419) |
0.21 |
(1593) |
0.43 |
(2109) |
20.0 |
(1362) |
43.0 |
(1768) |
50.2 |
(1277) |
38.0 |
(1630) |
37.4 |
(402) |
27.7 |
(1514) |
81.2 |
(177) |
3.82 |
(2064) |
14.00 |
(341) |
4.26 |
(1397) |
7.91 |
(2355) |
2.90 |
(1334) |
1.45 |
(1159) |
0.78 |
(1530) |
26.9 |
2.8 |
7.4 |
0.8 |
2.1 |
2.6 |
3.2 |
1.0 |
2.0 |
3.0 |
2.8 |
2.0 |
0.2 |
0.8 |
3.2 |
2.8 |
8.9 |
20.0 |
(1362) |
44.4 |
(1953) |
42.6 |
(1388) |
39.3 |
(1859) |
39.0 |
(376) |
26.6 |
(1538) |
81.2 |
(177) |
4.26 |
(1947) |
14.00 |
(341) |
4.46 |
(1422) |
8.34 |
(2357) |
3.99 |
(1026) |
1.99 |
(1078) |
0.99 |
(1496) |
30.2 |
3.0 |
7.7 |
0.8 |
2.0 |
2.8 |
3.5 |
1.1 |
2.2 |
3.3 |
3.0 |
2.1 |
0.2 |
1.0 |
2.9 |
3.1 |
9.6 |
| 2016 |
Galal Cancer |
KENT |
SR+ |
SG |
60.8% |
(1234) |
18.53 |
(1743) |
21.96 |
(1517) |
-3.43 |
(1712) |
49 |
(2235) |
30 |
(1525) |
513 |
() |
-1.37 |
(998) |
-0.66 |
(2409) |
0.45 |
(997) |
0.80 |
(1069) |
-1.38 |
(2661) |
1.17 |
() |
0.17 |
() |
0.37 |
() |
-0.55 |
() |
-0.15 |
() |
14.1 |
() |
43.2 |
(1799) |
46.3 |
(1883) |
36.9 |
(1781) |
31.2 |
(1127) |
64.1 |
(295) |
63.5 |
() |
2.49 |
(810) |
6.78 |
(1330) |
4.06 |
(1397) |
8.28 |
(2290) |
3.51 |
(514) |
2.03 |
(406) |
0.25 |
(2295) |
24.4 |
1.7 |
5.2 |
1.0 |
3.4 |
1.0 |
1.6 |
1.0 |
1.9 |
2.8 |
1.5 |
1.2 |
0.1 |
1.0 |
2.5 |
1.5 |
5.6 |
14.1 |
() |
49.7 |
() |
41.0 |
() |
43.4 |
() |
35.4 |
() |
65.1 |
() |
63.5 |
() |
2.80 |
() |
6.78 |
(1330) |
4.24 |
() |
8.75 |
() |
4.20 |
() |
2.41 |
() |
0.29 |
() |
24.5 |
1.9 |
4.9 |
1.1 |
3.2 |
1.1 |
1.7 |
0.9 |
1.8 |
2.8 |
1.5 |
1.2 |
0.1 |
1.0 |
2.2 |
1.5 |
5.9 |
| Date |
Opponent |
TAPE |
Result |
MIN |
2GM |
- |
2GA |
3GM |
- |
3GA |
FTM |
- |
FTA |
OFF |
DEF |
PF |
AST |
TO |
BLK |
STL |
PTS |
PENCIL |